Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Sympathetic ophthalmia (SO) is a bilateral granulomatous anterior uveitis usually occurring within the three months following trauma or a surgical procedure involving one eye.
1 FDA-approved treatment is available for sympathetic ophthalmia, including TRIAMCINOLONE ACETONIDE (TRIESENCE, approved 2007).
Brand Name | Generic Name | Mechanism | Approved | Market Status |
|---|---|---|---|---|
Estimated prevalence: 1-9 in 1,000,000 (Rare).
No clinical trials have been registered for sympathetic ophthalmia.
44 publications have been identified in PubMed for sympathetic ophthalmia. Research spans Case Report / Case Series (48%), Epidemiology / Natural History (20%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 21 | 48% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 8:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
TRIAMCINOLONE ACETONIDE |
— |
2007 |
Available |
View trials for sympathetic ophthalmia
9 |
20% |
Clinical study results | 6 | 14% |
Research summaries | 5 | 11% |
Laboratory research | 3 | 7% |
Atta S (2026). [PMID: 41505566](https://pubmed.ncbi.nlm.nih.gov/41505566/). *Retinal cases & brief reports*. [Clinical Trial Publication]
Samalia PD (2026). [PMID: 41642701](https://pubmed.ncbi.nlm.nih.gov/41642701/). *American journal of ophthalmology*. [Case Report / Case Series]
Narain S (2026). [PMID: 42008790](https://pubmed.ncbi.nlm.nih.gov/42008790/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Yang M (2026). [PMID: 41868577](https://pubmed.ncbi.nlm.nih.gov/41868577/). *Clin Ophthalmol*. [Case Report / Case Series]
Nakakura S (2026). [PMID: 41959971](https://pubmed.ncbi.nlm.nih.gov/41959971/). *Cureus*. [Case Report / Case Series]
Sakamoto T (2026). [PMID: 42205079](https://pubmed.ncbi.nlm.nih.gov/42205079/). *Ocul Immunol Inflamm*. [Clinical Trial Publication]
Bineshfar N (2026). [PMID: 41265721](https://pubmed.ncbi.nlm.nih.gov/41265721/). *American journal of ophthalmology*. [Epidemiology / Natural History]
Tefon Aribas AB (2026). [PMID: 41529112](https://pubmed.ncbi.nlm.nih.gov/41529112/). *European journal of ophthalmology*. [Clinical Trial Publication]
Flores-Sánchez BC (2025). [PMID: 39804100](https://pubmed.ncbi.nlm.nih.gov/39804100/). *Ocular immunology and inflammation*. [Case Report / Case Series]
Vienne-Jumeau A (2025). [PMID: 41098323](https://pubmed.ncbi.nlm.nih.gov/41098323/). *American journal of ophthalmology case reports*. [Case Report / Case Series]
AI-curated news mentioning sympathetic ophthalmia
Updated Aug 24, 2026
A recent study highlights the diagnostic and therapeutic challenges of sympathetic ophthalmia in patients with proliferative diabetic retinopathy during pregnancy. This research underscores the complexities faced by healthcare providers in managing these conditions simultaneously.